Evidence map›Paper›PMID 39589672›Full record

Trial reportAnnals of nuclear medicine2025

Sheng-Chieh Chan, Tsung-Lang Chiu, Shu-Hang Ng, Hung-Wen Kao, Sheng-Tzung Tsai, Shu-Hsin Liu

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sheng-Chieh ChanDepartment of Nuclear Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970423, Taiwan. williamsm.tw@gmail.com.ORCID http://orcid.org/0000-0003-3236-395X
Tsung-Lang ChiuDepartment of Neurosurgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970423, Taiwan.
Shu-Hang NgDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, 333423, Taiwan.
Hung-Wen KaoDepartment of Medical Imaging, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970423, Taiwan.
Sheng-Tzung TsaiDepartment of Neurosurgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970423, Taiwan.
Shu-Hsin LiuDepartment of Nuclear Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970423, Taiwan.

Funding

Buddhist Tzu Chi Medical Foundation TCMF-A 110-03[111]Buddhist Tzu Chi Medical Foundation TCMF-A 110-03[112]Hualien Tzu Chi Hospital TCRD113-035Ministry of Science and Technology, Taiwan 109-2314-B-303-015Ministry of Science and Technology, Taiwan 110-2314-B-303-014Ministry of Science and Technology, Taiwan 111-2314-B-303-006
6 · The paper itself

Abstract

objectiveThis prospective study aimed to evaluate the diagnostic value of fluorine-18-labeled fluoroethyltyrosine (

methodsPatients suspected of having primary or recurrent brain tumors were prospectively recruited. Each patient underwent

resultsFrom September 2019 to December 2023, 33 subjects were enrolled for reasons including suspected brain tumors (n = 20) or suspicious glioma recurrence (n = 8) on magnetic resonance imaging (MRI) and restaging for glioma (n = 5). Among the patients with suspected brain tumors or glioma recurrence on MRI, 25% had false-positive results.

conclusions

Indexed as

Brain NeoplasmsMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyTyrosineAdultAgedFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedProspective StudiesSensitivity and SpecificityYoung Adult(18F)fluoroethyltyrosineFluorodeoxyglucose F18TyrosineBrain neoplasmsGlioma, O-(2-[18F]-fluoroethyl)-L-tyrosine (FET)Positron emission tomography

Identifiers

PMID39589672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.